Testing effectiveness (Phase 2)Ended earlyNCT04990440
What this trial is testing
Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis
Who this might be right for
Dermatitis, Atopic
Janssen Research & Development, LLC 6